BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 30599763)

  • 21. Clozapine-induced myocarditis: recognizing a potentially fatal adverse reaction.
    Hatton JL; Bhat PK; Gandhi S
    Tex Heart Inst J; 2015 Apr; 42(2):155-7. PubMed ID: 25873829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical course and analysis of ten fatal cases of clozapine-induced myocarditis and comparison with 66 surviving cases.
    Ronaldson KJ; Fitzgerald PB; Taylor AJ; Topliss DJ; McNeil JJ
    Schizophr Res; 2011 May; 128(1-3):161-5. PubMed ID: 21320766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clozapine Rechallenge After Major Adverse Effects: Clinical Guidelines Based on 259 Cases.
    Manu P; Lapitskaya Y; Shaikh A; Nielsen J
    Am J Ther; 2018; 25(2):e218-e223. PubMed ID: 29505490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocarditis related to clozapine treatment.
    Hägg S; Spigset O; Bate A; Soderström TG
    J Clin Psychopharmacol; 2001 Aug; 21(4):382-8. PubMed ID: 11476122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible myocarditis in a patient receiving clozapine.
    Kirpekar VC; Deshpande SM; Joshi PP
    Indian Heart J; 2001; 53(6):779-81. PubMed ID: 11838936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clozapine-induced myocarditis in Canada: Evidence from spontaneous reports.
    Neufeld NH; Remington G
    Schizophr Res; 2019 Apr; 206():462-463. PubMed ID: 30514645
    [No Abstract]   [Full Text] [Related]  

  • 27. Myocarditis associated with clozapine treatment.
    Degner D; Bleich S; Grohmann R; Bandelow B; Rüther E
    Aust N Z J Psychiatry; 2000 Oct; 34(5):880. PubMed ID: 11037387
    [No Abstract]   [Full Text] [Related]  

  • 28. Myocarditis after administration of clozapine.
    Kontoangelos K; Loizos S; Kanakakis J; Smyrnis N; Economou M; Bergiannaki JD; Papadimitriou GN
    Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2383-6. PubMed ID: 25219841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-reactive protein: an early critical sign of clozapine-related myocarditis.
    Fehily SR; Forlano R; Fitzgerald PB
    Australas Psychiatry; 2016 Apr; 24(2):181-4. PubMed ID: 26400456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on the adverse effects of clozapine: focus on myocarditis.
    De Berardis D; Serroni N; Campanella D; Olivieri L; Ferri F; Carano A; Cavuto M; Martinotti G; Cicconetti A; Piersanti M; Saverio Moschetta F; Di Giannantonio M
    Curr Drug Saf; 2012 Feb; 7(1):55-62. PubMed ID: 22663959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Safety aspects during treatment with clozapine. : Monitoring and rechallenge - a narrative review].
    Berger SJ; Hofer A
    Neuropsychiatr; 2023 Sep; 37(3):130-135. PubMed ID: 37389803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 12-month audit of clozapine associated myocarditis in a South Australian Local Health Network: The importance of screening and personalised titration.
    Carswell O; Wilton LR; Nicholls K; Thomas V; Clark SR
    Schizophr Res; 2024 Jun; 268():88-93. PubMed ID: 37722933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clozapine-induced myocarditis may be associated with rapid titration: A case report verified with autopsy.
    Chopra N; de Leon J
    Int J Psychiatry Med; 2016; 51(1):104-15. PubMed ID: 26681239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clozapine-induced myocarditis after long-term treatment: case presentation and clinical perspectives.
    Lang UE; Willbring M; von Golitschek R; Schmeisser A; Matschke K; Malte Tugtekin S
    J Psychopharmacol; 2008 Jul; 22(5):576-80. PubMed ID: 18308817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of detection of myocarditis induced by clozapine: With and without cardiac monitoring.
    Anıl Yağcıoğlu AE; Ertuğrul A; Karakaşlı AA; Ağaoğlu E; Ak S; Karahan S; Yazıcı MK
    Psychiatry Res; 2019 Sep; 279():90-97. PubMed ID: 31362146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic review and meta-analysis of rates of clozapine-associated myocarditis and cardiomyopathy.
    Siskind D; Sidhu A; Cross J; Chua YT; Myles N; Cohen D; Kisely S
    Aust N Z J Psychiatry; 2020 May; 54(5):467-481. PubMed ID: 31957459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clozapine-Induced Myocarditis in a Young Man with Refractory Schizophrenia: Case Report of a Rare Adverse Event and Review of the Literature.
    Adetiloye AO; Abdelmottaleb W; Ahmed MF; Victoria AM; Ozbay MB; Valencia Manrique JC; Alaameri R; Badero O; Mushiyev S
    Am J Case Rep; 2022 Jul; 23():e936306. PubMed ID: 35793273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clozapine induced myopericarditis: early recognition improves clinical outcome.
    Razminia M; Salem Y; Devaki S; Shah N; Khosla S
    Am J Ther; 2006; 13(3):274-6. PubMed ID: 16772769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case-control study.
    Ronaldson KJ; Fitzgerald PB; Taylor AJ; Topliss DJ; Wolfe R; McNeil JJ
    Schizophr Res; 2012 Nov; 141(2-3):173-8. PubMed ID: 23010488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clozapine-induced cardiomyopathy and myocarditis monitoring: A systematic review.
    Knoph KN; Morgan RJ; Palmer BA; Schak KM; Owen AC; Leloux MR; Patel M; Leung JG
    Schizophr Res; 2018 Sep; 199():17-30. PubMed ID: 29548760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.